| First Author | Fukuda T | Year | 2019 |
| Journal | PLoS One | Volume | 14 |
| Issue | 11 | Pages | e0224967 |
| PubMed ID | 31730661 | Mgi Jnum | J:282174 |
| Mgi Id | MGI:6379732 | Doi | 10.1371/journal.pone.0224967 |
| Citation | Fukuda T, et al. (2019) CAMDI interacts with the human memory-associated protein KIBRA and regulates AMPAR cell surface expression and cognition. PLoS One 14(11):e0224967 |
| abstractText | Little is known about the molecular mechanisms of cognitive deficits in psychiatric disorders. CAMDI is a psychiatric disorder-related factor, the deficiency of which in mice results in delayed neuronal migration and psychiatrically abnormal behaviors. Here, we found that CAMDI-deficient mice exhibited impaired recognition memory and spatial reference memory. Knockdown of CAMDI in hippocampal neurons increased the amount of internalized alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor (AMPAR) and attenuated the chemical long-term potentiation (LTP)-dependent cell surface expression of AMPAR. KIBRA was identified as a novel CAMDI-binding protein that retains AMPAR in the cytosol after internalization. KIBRA inhibited CAMDI-dependent Rab11 activation, thereby attenuating AMPAR cell surface expression. These results suggest that CAMDI regulates AMPAR cell surface expression during LTP. CAMDI dysfunction may partly explain the mechanism underlying cognitive deficits in psychiatric diseases. |
